Q4 2026 Ajanta Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day and welcome to Ajanta Pharma Q4FY 2026 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Yogesh Agarwal, Managing Director of Ajanta Pharma Limited. Thank you, and over to you, sir.
Thank you. Good afternoon, everyone, and welcome to Ajanta. With me, I have Mr. Rajeev Agrawal, our Joint Managing Director; Mr. Arvind Agrawal, our CFO; Mr. Rajeev Agarwal, our VP Finance and Investor Relations.
I hope all of you have received the financial results by now. I will take you with our overall business performance first.
It is a pleasure to share that Ajanta has achieved several important milestones in FY 2026, with revenue surpassing INR5,000 crores and net profit crossing INR1,000 crores. This marks a significant step forward in our growth journey. The year reflects strong, well-rounded performance across all areas of business, reinforcing the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
